• About us
• Contact

Advertisement

Person › Details

Michael Motschmann (MIG Fonds (Group))

Motschmann, Michael (MIG Funds 200604)

 

	Organisation	MIG Fonds (Group)
	Product	venture capital
	Product 2	LIFE SCIENCES

Record changed: 2023-03-23

Advertisement

More documents for Michael Motschmann

• [1] AC Immune S.A.. (7/27/21). "Press Release: AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH". Lausanne....
• [2] AdvanceCor GmbH. (6/2/20). "Press Release: AdvanceCor GmbH Closes a further Financing Round with a Consortium of Investors". München/Martinried....
• [3] Temedica GmbH. (1/14/20). "Press Release: Temedica Raises $19 Million Series B Funding". Munich....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.